The Relative Strength (RS) Rating for Inspire Medical Systems climbed into a new percentile Wednesday, as it got a lift from 65 to 71.
IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
Over 100 years of market history reveals that the market's biggest winners typically have an RS Rating of over 80 as they launch their largest climbs. See if Inspire Medical Systems can continue to show renewed price strength and hit that benchmark.
Can You Really Time The Stock Market?
Inspire Medical Systems is working on a consolidation with a 225.00 entry. See if it can break out in heavy trading.
Inspire Medical Systems showed 0% earnings growth in the latest quarterly report. Revenue gains came in at 33%.
The company earns the No. 20 rank among its peers in the Medical-Products industry group. LeMaitre Vascular, Globus Medical and Pro-Dex are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
